Updated:
Sanofi Ventures
Sanofi Ventures is the corporate venture capital arm of Sanofi and a strategic venture fund. It invests in early-stage biotech and digital health companies,...
Sanofi Ventures
Sanofi Ventures is the corporate venture capital arm of Sanofi and a strategic venture fund. It invests in early-stage biotech and digital health companies, serving as an entry point to the innovation ecosystem for Sanofi. The firm strategically invests in early-stage transformational science and technology when companies are too early to partner with or acquire, and invests across the private company lifecycle from Seed to Series B and beyond.
General information
Firm type
Venture Capital
Year founded
2001
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Additional offices
Cambridge · New York · Paris
Principals
Jason P. Hafler
Managing Director
Laia Crespo
Partner
Cris De Luca
Partner
Paulina Hill
Partner
Christopher Gagliardi
Principal
Meg Krench
Principal
Kriti Subramanyam
Director of Investments
Francesc Dosrius Lleonart
Associate Director of Investments
Pierre Gaudeaux
Associate Director of Investments
Rebecca Gorelov
Associate Director of Investments
Steve Bychowski
Sanofi Ventures General Counsel
Anne Jammal
Executive Assistant
Sector focus
Frequently asked questions
What sectors does Sanofi Ventures explicitly invest in?
The firm's mandate centers on biotherapeutics and digital health. This includes companies developing new drug platforms, novel therapeutic modalities, and health technologies that focus on improving patient outcomes and transforming the practice of medicine.
Where does Sanofi Ventures invest geographically?
Sanofi Ventures maintains a transatlantic investment posture. It has offices in Palo Alto, Cambridge, and New York to cover the US East and West coast innovation ecosystems, alongside a presence in Paris to access European life sciences startups.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: